John C. Martin

DIRECTOR · SAREPTA THERAPEUTICS, INC. · CIK 0001190578

FILING MIX · LIFETIME100%/0%

BUYS

SELLS

TOTAL VALUE

COMPANIES

ACTIVE SINCE

Feb 2020

HOLDINGS NOW

5,518

AVG SELL PX

—

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

No backtest data available for John C. Martin. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.

Holdings over time

SRPT · 5,518 shares · as of Mar 3, 2021

Trading cadence · quarterly flow

BUY ● SELL ●

2020

2021

FLOW · 6 buys / 0 sellsCOVERAGE · 5 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED
SRPT SAREPTA THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	2,726	—	—	7,913	Mar 3, 2021	Mar 5, 2021 ↗
SRPT SAREPTA THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	5,518	—	—	5,518	Mar 3, 2021	Mar 5, 2021 ↗
SRPT SAREPTA THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	3,685	—	—	3,685	Feb 28, 2020	Feb 28, 2020 ↗
SRPT SAREPTA THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	2,075	—	—	5,187	Feb 28, 2020	Feb 28, 2020 ↗
SRPT SAREPTA THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	5,528	—	—	5,528	Feb 28, 2020	Feb 28, 2020 ↗
SRPT SAREPTA THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	3,112	—	—	3,112	Feb 28, 2020	Feb 28, 2020 ↗

Other insiders · SRPT

Loading peer insiders…

About this filer

CIK 0001190578

ROLE

Director

PRIMARY

SRPT

COMPANIES

ACTIVE SINCE

Feb 2020

MARKETPEEL · /INSIDER/0001190578DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

The morning brief, before the bell.